AR022044A1 - Derivados de 1,5-benzodiazepina - Google Patents

Derivados de 1,5-benzodiazepina

Info

Publication number
AR022044A1
AR022044A1 ARP000102119A ARP000102119A AR022044A1 AR 022044 A1 AR022044 A1 AR 022044A1 AR P000102119 A ARP000102119 A AR P000102119A AR P000102119 A ARP000102119 A AR P000102119A AR 022044 A1 AR022044 A1 AR 022044A1
Authority
AR
Argentina
Prior art keywords
benzodiazepina
derivatives
cck
obesity
diseases
Prior art date
Application number
ARP000102119A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR022044A1 publication Critical patent/AR022044A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP000102119A 1999-05-06 2000-05-03 Derivados de 1,5-benzodiazepina AR022044A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process

Publications (1)

Publication Number Publication Date
AR022044A1 true AR022044A1 (es) 2002-09-04

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102119A AR022044A1 (es) 1999-05-06 2000-05-03 Derivados de 1,5-benzodiazepina

Country Status (21)

Country Link
EP (1) EP1212305A2 (no)
JP (1) JP2002544200A (no)
KR (1) KR20020012567A (no)
CN (1) CN1161345C (no)
AR (1) AR022044A1 (no)
AU (1) AU4754800A (no)
BR (1) BR0010338A (no)
CA (1) CA2370801A1 (no)
CO (1) CO5170461A1 (no)
CZ (1) CZ20013988A3 (no)
HK (1) HK1046138A1 (no)
HU (1) HUP0201181A3 (no)
IL (1) IL146124A0 (no)
MX (1) MXPA01011267A (no)
MY (1) MY138319A (no)
NO (1) NO20015397L (no)
NZ (1) NZ515048A (no)
PE (1) PE20010110A1 (no)
PL (1) PL351546A1 (no)
TR (1) TR200103169T2 (no)
WO (1) WO2000068209A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
GEP20094723B (en) 2004-05-25 2009-07-10 Pfizer Prod Inc Tetraazabenzo [e] azulene derivatives and analogs thereof
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
JP2002544200A (ja) 2002-12-24
MXPA01011267A (es) 2002-05-06
MY138319A (en) 2009-05-29
WO2000068209A3 (en) 2001-03-01
WO2000068209A2 (en) 2000-11-16
BR0010338A (pt) 2002-02-13
EP1212305A2 (en) 2002-06-12
KR20020012567A (ko) 2002-02-16
TR200103169T2 (tr) 2002-04-22
HK1046138A1 (zh) 2002-12-27
CA2370801A1 (en) 2000-11-16
HUP0201181A3 (en) 2003-10-28
NZ515048A (en) 2004-01-30
CZ20013988A3 (cs) 2002-02-13
PE20010110A1 (es) 2001-03-05
CO5170461A1 (es) 2002-06-27
IL146124A0 (en) 2002-07-25
AU4754800A (en) 2000-11-21
CN1161345C (zh) 2004-08-11
CN1362949A (zh) 2002-08-07
PL351546A1 (en) 2003-05-05
NO20015397D0 (no) 2001-11-05
HUP0201181A2 (hu) 2002-12-28
NO20015397L (no) 2001-11-05

Similar Documents

Publication Publication Date Title
AP2000001860A0 (en) Hypolipidemic benzothiazepine compounds.
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
SE9903544D0 (sv) Novel compounds
BR0010555A (pt) Inibidores de neuraminidases
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
PT1213296E (pt) Derivados de glucopiranosiloxipirazole composicoes medicas que os contem e intermediarios na sua producao
PA8547701A1 (es) Nucleosidos 4 substituidos.
BR0011448A (pt) Imidazoquinolinas substituìdas por amida
LU91145I9 (no)
BR0312729A (pt) Novos derivados de indol-3-enxofre
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
ATE406893T1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
SE8505488D0 (sv) Isosilybinfri silibinin
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
ES2182035T3 (es) Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa.
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
AR022044A1 (es) Derivados de 1,5-benzodiazepina

Legal Events

Date Code Title Description
FB Suspension of granting procedure